{"ORPHApacket":[{"ORPHApacketID":"71279","date":"2019-12-05 18:13:27","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"71279","Name":[{"lang":"en","label":"CANOMAD syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_71279","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare neuroinflammatory or neuroimmunological disease"}],"ORPHA":"182064","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_182064"},{"Name":[{"lang":"en","label":"Chronic acquired demyelinating polyneuropathy"}],"ORPHA":"208974","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_208974"},{"Name":[{"lang":"en","label":"Peripheral neuropathy associated with monoclonal gammopathy"}],"ORPHA":"209010","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_209010"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A rare chronic immune-mediated polyneuropathy characterized by a progressive disabling neuropathy with marked gait disturbance primarily due to sensory ataxia with concurrent cranial neuropathies (internal or external ophthalmoplegia, dysphagia, dysarthria, or facial weakness) and anti-disialosyl IgM antibodies."}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]},{"Name":[{"lang":"en","label":"Elderly"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"CANDA syndrome"},{"lang":"en","label":"Chronic ataxic neuropathy-ophthalmoplegia-IgM paraprotein-cold agglutinins-disialosyl antibodies syndrome"},{"lang":"en","label":"Chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies"}]}]}]}